Damla Etal

Damla Etal is a Senior Research Scientist at AstraZeneca, where they demonstrate a strong commitment to clinical project management and comprehensive NGS laboratory coordination. With seven years of experience in executing NGS methods, they have developed expertise in various methodologies, including RNA-seq, DNA-seq, and 10X Single Cell Transcriptomics. Previously, Damla served as a Project Intern at Sveriges lantbruksuniversitet, focusing on breast cancer metastasis using CRISPR/Cas9, and worked as a Research Consultant at Dfind Science & Engineering, outsourced to AstraZeneca. Damla holds a Master’s degree in Infection Biology from Uppsala University and a Bachelor’s degree in Biomedical Sciences from Linköpings universitet.